Literature DB >> 8334671

The molecular biology of carcinogenesis.

H C Pitot1.   

Abstract

Carcinogenesis may result from the action of any one or a combination of chemical, physical, biologic, and/or genetic insults to cells. The process of carcinogenesis may be divided into at least three stages: initiation, promotion, and progression. The first stage of carcinogenesis, initiation, results from an irreversible genetic alteration, most likely one or more simple mutations, transversions, transitions, and/or small deletions in DNA. The reversible stage of promotion does not involve changes in the structure of DNA but rather in the expression of the genome mediated through promoter-receptor interactions. The final irreversible stage of progression is characterized by karyotypic instability and malignant growth. Critical molecular targets during the stages of carcinogenesis include proto-oncogenes, cellular oncogenes, and tumor suppressor genes, alterations in both alleles of the latter being found only in the stage of progression. Although many of these critical target genes have been identified, the ultimate number and characteristics of molecular alterations that define neoplasia have not been elucidated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334671     DOI: 10.1002/1097-0142(19930801)72:3+<962::aid-cncr2820721303>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  39 in total

1.  The cell and molecular biological approach to biomaterial research: a perspective.

Authors:  C J Kirkpatrick; M Wagner; H Köhler; F Bittinger; M Otto; C L Klein
Journal:  J Mater Sci Mater Med       Date:  1997-03       Impact factor: 3.896

Review 2.  Stage-specific gene expression during hepatocarcinogenesis in the rat.

Authors:  H C Pitot
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

Authors:  Di Chen; Sheng Biao Wan; Huanjie Yang; Jian Yuan; Tak Hang Chan; Q Ping Dou
Journal:  Adv Clin Chem       Date:  2011       Impact factor: 5.394

4.  Histone deacetylase inhibitors -Promising agents for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer-.

Authors:  Youichirou Matsuzaki; Yoshihiro Sowa; Tohru Hirose; Tomoya Yokota; Toshiyuki Sakai
Journal:  Environ Health Prev Med       Date:  2003-11       Impact factor: 3.674

5.  INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer.

Authors:  Youichirou Matsuzaki; Toshiyuki Sakai
Journal:  Environ Health Prev Med       Date:  2005-03       Impact factor: 3.674

6.  Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.

Authors:  Li Sheng-Fowler; Fang Cai; Haiqing Fu; Yong Zhu; Brian Orrison; Gideon Foseh; Don G Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Journal:  Int J Biol Sci       Date:  2010-03-29       Impact factor: 6.580

Review 7.  Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.

Authors:  Deilson Elgui de Oliveira; Bárbara G Müller-Coan; Joseph S Pagano
Journal:  Trends Microbiol       Date:  2016-04-07       Impact factor: 17.079

Review 8.  Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products.

Authors:  Manjinder Kaur; Chapla Agarwal; Rajesh Agarwal
Journal:  J Nutr       Date:  2009-07-29       Impact factor: 4.798

Review 9.  Tea polyphenols, their biological effects and potential molecular targets.

Authors:  D Chen; V Milacic; M S Chen; S B Wan; W H Lam; C Huo; K R Landis-Piwowar; Q C Cui; A Wali; T H Chan; Q P Dou
Journal:  Histol Histopathol       Date:  2008-04       Impact factor: 2.303

Review 10.  Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.

Authors:  Derek V Seidel; M Andrea Azcárate-Peril; Robert S Chapkin; Nancy D Turner
Journal:  Semin Cancer Biol       Date:  2017-07-01       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.